Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ErbB2/Her2 antibody

ErbB2/Her2 Reactivity: Human WB, IF, FACS, IHC (p), IP, IHC (fro), IEM Host: Mouse Monoclonal 9G6 unconjugated
Catalog No. ABIN920577
  • Target See all ErbB2/Her2 Antibodies
    ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))
    Reactivity
    • 422
    • 125
    • 120
    • 33
    • 8
    • 5
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 278
    • 151
    • 10
    • 6
    • 3
    • 2
    • 1
    • 1
    Mouse
    Clonality
    • 280
    • 169
    • 2
    Monoclonal
    Conjugate
    • 275
    • 20
    • 17
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 7
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    This ErbB2/Her2 antibody is un-conjugated
    Application
    • 283
    • 134
    • 100
    • 93
    • 91
    • 89
    • 80
    • 60
    • 54
    • 51
    • 29
    • 20
    • 12
    • 9
    • 8
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoelectron Microscopy (IEM)
    Characteristics
    Tumour marker
    Purification
    The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
    Clone
    9G6
    Isotype
    IgG1
    Top Product
    Discover our top product ErbB2/Her2 Primary Antibody
  • Comment

    Host: Mouse (Balb/c)

    Restrictions
    For Research Use only
  • Storage
    4 °C/-20 °C
  • van de Vijver, Peterse, Mooi, Wisman, Lomans, Dalesio, Nusse: "Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer." in: The New England journal of medicine, Vol. 319, Issue 19, pp. 1239-45, (1988) (PubMed).

  • Target
    ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))
    Alternative Name
    Neu-Oncogen / C-Erb B2 (ErbB2/Her2 Products)
    Pathways
    RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Skeletal Muscle Fiber Development
You are here:
Support